U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07322913) titled 'Intervascular Post-Market Clinical Follow-Up (PMCF) Registry' on Nov. 20, 2025.
Brief Summary: The purpose of this registry is to evaluate the long-term safety and performance of Intervascular Vascular Grafts and Patches (Intergard Standard, Hemashield, Intergard Silver, Intergard Synergy) for bypass, repair or replacement of aortic, peripheral, or carotid arteries. This registry is intended to further define the expected product lifetime of the devices and to collect data related to usefulness of the antimicrobial coatings.
Study Start Date: Dec. 19, 2025
Study Type: OBSERVATIONAL
Condition:
Carotid Artery Diseases
Aortic Diseas...